Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT06171958
Eligibility Criteria:
Inclusion Criteria:
* eGFR \<30 mL/min/1.73m2, calculated with the revised Lund-Malmö formula and plasma creatinine.
* Medical need of either an ICM-enhanced or unenhanced CT
Exclusion Criteria:
* \<18 years of age
* Ongoing renal replacement therapy
* Ongoing treatment with nephrotoxic drugs. Drugs classified as nephrotoxic are acyclovir, aminoglycosides, ciclosporins, cisplatin, methotrexate, non-steroidal anti-inflammatory drugs (except low-dose aspirin) and vancomycin administered intravenously.
* Known allergy to ICM who and have not received prophylactic treatment (if patient belongs to ICM arm)
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06171958
Study Brief:
Protocol Section:
NCT06171958